Works matching Inflammatory bowel disease treatment

Results: 2460
    1
    2
    3
    4
    5
    6
    7

    Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases.

    Published in:
    Digestive Endoscopy, 2025, v. 37, n. 4, p. 319, doi. 10.1111/den.15002
    By:
    • Matsumoto, Takayuki;
    • Hisamatsu, Tadakazu;
    • Esaki, Motohiro;
    • Omori, Teppei;
    • Sakuraba, Hirotake;
    • Shinzaki, Shinichiro;
    • Sugimoto, Ken;
    • Takenaka, Kento;
    • Naganuma, Makoto;
    • Bamba, Shigeki;
    • Hisabe, Takashi;
    • Hiraoka, Sakiko;
    • Fujiya, Mikihiro;
    • Matsuura, Minoru;
    • Yanai, Shunichi;
    • Watanabe, Kenji;
    • Ogata, Haruhiko;
    • Andoh, Akira;
    • Nakase, Hiroshi;
    • Ohtsuka, Kazuo
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease.

    Published in:
    Scandinavian Journal of Gastroenterology, 2020, v. 55, n. 7, p. 786, doi. 10.1080/00365521.2020.1779340
    By:
    • Judge, Ciaran;
    • McGettigan, Neasa;
    • Ryan, Timothy;
    • Hazel, Karl;
    • Singh, Pamla;
    • Parihar, Vikrant;
    • Stack, Roisin;
    • O'Connor, Anthony;
    • Dunne, Cara;
    • Cullen, Garret;
    • Egan, Laurence;
    • Harewood, Gavin;
    • MacCarthy, Finbar;
    • McKiernan, Susan;
    • Mulcahy, Hugh;
    • Murray, Frank;
    • Patchett, Stephen;
    • Sheridan, Juliette;
    • Cheriyan, Danny;
    • Farrell, Richard
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease.

    Published in:
    Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00039
    By:
    • Lichnog, Charlotte;
    • Klabunde, Sha;
    • Becker, Emily;
    • Fuh, Franklin;
    • Tripal, Philipp;
    • Atreya, Raja;
    • Klenske, Entcho;
    • Erickson, Rich;
    • Chiu, Henry;
    • Reed, Chae;
    • Chung, Shan;
    • Neufert, Clemens;
    • Atreya, Imke;
    • McBride, Jacqueline;
    • Neurath, Markus F.;
    • Zundler, Sebastian
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα Resumption

    Published in:
    Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae327
    By:
    • Amoura, Ariane;
    • Frapard, Thomas;
    • Treton, Xavier;
    • Surgers, Laure;
    • Beaugerie, Laurent;
    • Lafaurie, Matthieu;
    • Gornet, Jean Marc;
    • Lepeule, Raphaël;
    • Amiot, Aurélien;
    • Canouï, Etienne;
    • Abitbol, Vered;
    • Froissart, Antoine;
    • Vidon, Mathias;
    • Nguyen, Yann;
    • Lefort, Agnès;
    • Zarrouk, Virginie
    Publication type:
    Article
    38

    Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 7, p. 1174, doi. 10.1111/apt.16039
    By:
    • Vasudevan, Abhinav;
    • Parthasarathy, Nina;
    • Con, Danny;
    • Nicolaides, Steven;
    • Apostolov, Ross;
    • Chauhan, Ayushi;
    • Bishara, Maria;
    • Luber, Raphael P.;
    • Joshi, Neetima;
    • Wan, Anna;
    • Rickard, James A.;
    • Long, Tony;
    • Connoley, Declan;
    • Sparrow, Miles P.;
    • Gibson, Peter R.;
    • Langenberg, Daniel R.
    Publication type:
    Article
    39
    40

    Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.

    Published in:
    Journal of Gastroenterology, 2024, v. 59, n. 6, p. 468, doi. 10.1007/s00535-024-02099-7
    By:
    • Makuuchi, Motoki;
    • Kakuta, Yoichi;
    • Umeno, Junji;
    • Fujii, Toshimitsu;
    • Takagawa, Tetsuya;
    • Ibuka, Takashi;
    • Miura, Miki;
    • Sasaki, Yu;
    • Takahashi, Sakuma;
    • Nakase, Hiroshi;
    • Kiyohara, Hiroki;
    • Tominaga, Keiichi;
    • Shimodaira, Yosuke;
    • Hiraoka, Sakiko;
    • Ueno, Nobuhiro;
    • Yanai, Shunichi;
    • Yoshihara, Takeo;
    • Kakimoto, Kazuki;
    • Matsuoka, Katsuyoshi;
    • Hayashi, Ryohei
    Publication type:
    Article
    41
    42
    43

    Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases.

    Published in:
    Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241290636
    By:
    • Bacsur, Péter;
    • Resál, Tamás;
    • Sarlós, Patrícia;
    • Iliás, Ákos;
    • Sümegi, Liza Dalma;
    • Kata, Diána;
    • Dávid, Anett;
    • Farkas, Bernadett;
    • Ivány, Emese;
    • Bálint, Anita;
    • Bősze, Zsófia;
    • Fábián, Anna;
    • Bor, Renáta;
    • Szepes, Zoltán;
    • Afif, Waqqas;
    • Bessissow, Talat;
    • Farkas, Klaudia;
    • Lakatos, Péter L.;
    • Molnár, Tamás
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.

    Published in:
    2017
    By:
    • Greuter, Thomas;
    • Bertoldo, Fabio;
    • Rechner, Roman;
    • Straumann, Alex;
    • Biedermann, Luc;
    • Zeitz, Jonas;
    • Misselwitz, Benjamin;
    • Scharl, Michael;
    • Rogler, Gerhard;
    • Safroneeva, Ekaterina;
    • Ali, Raja A. R.;
    • Braegger, Christian;
    • Heyland, Klaas;
    • Mueller, Pascal;
    • Nydegger, Andreas;
    • Petit, Laetitia-Marie;
    • Schibli, Susanne;
    • Furlano, Raoul I.;
    • Spalinger, Johannes;
    • Schäppi, Michela
    Publication type:
    journal article